J.P. Morgan Chase & Co.

J.P. Morgan Chase & Co. is out with a research report on Mako Surgical (NASDAQ: MAKO) and it is raising its price target to $37 from $28, but is keeping its Neutral rating after it reported earnings. In a note to clients, J.P. Morgan Chase & Co. writes, "Mako reported 3Q results Wednesday...

J.P. Morgan Chase & Co. is out with a research report on ESCO Technologies Inc. (NYSE: ESE) and it has a Neutral rating, and it is raising its price target to $43 from $39.50. In a note to clients, J.P. Morgan Chase & Co. writes, "ESE reported strong F4Q results ahead of consensus...

J.P. Morgan Chase & Co. is out with a research report on TRW Automotive (NYSE: TRW) and it has an Overweight rating on shares, but is lowering its price target to $53 from $69. In a note to clients, J.P. Morgan Chase & Co. writes, "The one bright spot to emerge from the call was that TRW's...

J.P. Morgan Chase & Co. is out with a research report on Visteon Corp. (NYSE: VC) and is reiterating its Overweight rating and $71 price target on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "A Bloomberg article late Friday indicated that Visteon is exploring the sale of...

J.P. Morgan Chase & Co. is out with a research report on Commercial Vehicle Group (NASDAQ: CVGI) and it is raising its price target to $13 from $12, but it is keeping its Neutral rating on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "CVGI (N) posted a Q3 operating...

J.P. Morgan Chase & Co. is out with a research report on D&B (NYSE: DNB) and it has a Neutral rating and a $73 price target on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "We're maintaining our Neutral rating on DNB following Q3,11 results. Revenues rose 2-3% (ex...

J.P. Morgan Chase & Co. is out with a research report on PMC-Sierra (NASDAQ: PMCS) and is downgrading shares to Neutral from Overweight, and is lowering its price target to $7.50 from $9. In a note to clients, J.P. Morgan Chase & Co. writes, "We are downgrading PMCS to Neutral from OW....

J.P. Morgan Chase & Co. is out with a research report on HealthSouth Corp (NYSE: HLS) and it is lowering its price target to $25 from $28, but is keeping its Neutral rating on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "HealthSouth reported 3Q11 EPS of $0.17/share...

J.P. Morgan Chase & Co. is out with a research report on Ariba, Inc (NASDAQ: ARBA) and it remains Overweight with a $33 price target on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "Ariba reported their FY4Q11 exceeding our estimates, backlog, and deal metrics pointing to...

J.P. Morgan Chase & Co. is out with a research report on Compass Minerals International (NYSE: CMP) and is lowering its price target to $81 from $83, but is keeping its Neutral rating on shares. In a note to clients, J.P. Morgan Chase & Co. writes, "Compass Minerals is contending with the...